Affinity chromatography was first developed in the 1930s by Swedish biochemist Arne Tiselius. It relies on the reversible binding of biochemical compounds to separate and purify proteins and other molecules. Specificity is based on the matrix, spacer arm, and ligand. The sample is injected and molecules that bind to the ligand are retained on the column while others pass through. The retained molecules can then be eluted by changing pH or solvent concentration. Affinity chromatography is used to purify antibodies, enzymes, nucleic acids, and other biomolecules.